Program Goals

The program is designed to meet the educational needs of healthcare and laboratory professionals who are involved in the research, diagnosis and treatment of breast cancer.

Target Audience

The program is designed to meet the needs of physicians and other healthcare professionals interested in the management of breast cancer patients.

Educational Objectives

After completing this activity, the participant should be able to:

1. Discuss the clinical trials of trastuzumab (Herceptin) in the adjuvant setting including the NSABP B-31, NCCTG N9831, HERA clinical trial, and BCIRG006 clinical trial.
2. Summarize the inclusion criteria for entry to these clinical trials.
3. Compare HER-2 immunohistochemistry assay results with HER-2 fluorescence in situ hybridization assay results from women eligible for entry to the BCIRG006 clinical trial.

Faculty

Michael Fredrick Press, MD, PhD
Professor, Department of Pathology
Norris Comprehensive Cancer Center
Keck School of Medicine
The University of Southern California
Los Angles, California

Agenda

• 05 minutes: Welcome & Introduction
• 40 minutes: Didactic Presentation
• 10 minutes Q&A Session
• 05 minutes: Evaluation & Post-Test

Disclosure of Conflicts of Interests

Instructors, planners, managers and other individuals who are in a position to control the content of this activity are required to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME and P.A.C.E.^® accredited activity:

Planners and Managers

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Employees of the accredited providers for this activity, and employees of Dane Garvin Ltd. have disclosed that they have no significant financial relationships.

CME (ACCME) Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative (MEC) and Dane Garvin Ltd. Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation - Physician, CME

Medical Education Collaborative designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

How to Obtain CME Credit

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.0 AMA PRA Category 1 Credit™. To receive credit, the course must be completed before August 2007.

If you attended the live presentation on June 27, 2006, and have already received CME credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

• Read all of the CME accreditation information above.
• View the complete webcast program.
• Click on the link to apply for CME credits.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
• After successfully completing the online test and evaluation, your application will be processed by the CME provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.

Should you have any CME questions regarding this activity, please contact:
Medical Education Collaborative
651 Corporate Circle, Suite 104
Golden, CO 80401
866.420.3252 (toll free)
303.420.3259 (fax)
https://www.meccme.org/

Credit Designation - Lab Professional, P.A.C.E.^®

This program is approved for 1.0 contact hour of continuing education in the clinical laboratory sciences through the ASCLS P.A.C.E.® Program.

How to Obtain P.A.C.E.^® Credit

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed before August 2007. No post-test is required through December 31, 2006; after that date a quiz must be completed to earn credit.  

If you attended the live presentation on June 27, 2006, and have already received P.A.C.E.® credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:

• Read all of the information above.
• View the complete webcast program.
• Click on the link to apply for P.A.C.E.® credit.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 70% (if taken after December 27, 2006) and answer all evaluation questions to receive a certificate.
• After successfully completing the online test and/or evaluation, your application will be processed by the P.A.C.E.® provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.

Should you have any P.A.C.E.® questions regarding this activity, please contact:

ASCLS P.A.C.E.^®
1861 International Drive, Suite 200
Tysons Corner, VA 22102
Ph: 571-748-3776
Fx: 571-354-7576
https://www.ascls.org/

Release and Expiration

Release Date: August 2006
Expiration date: August 2007

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The accreditation providers and Dane Garvin Ltd. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Dane Garvin Ltd. protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Dane Garvin Ltd. will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Dane Garvin, Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.

“HER2 as a Target for the Adjuvant Treatment of Breast Cancer”

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Cosponsor

     This activity is co-sponsored by the Association for Molecular Pathology.

Commercial Support Statement

    This activity supported by an educational grant from Abbott Molecular.

Copyright

Copyright © August 2006 - Present.    Dane Garvin, Ltd. All Rights Reserved.   Permission for accreditation use previously granted to the CME Provider and the American Society for Clinical Laboratory Science (ASCLS).